Author: Bayh-Dole Coalition

21 Jul NIH Intramural Licensing Guidelines Hit the Wrong Note at the Wrong Time

Posted at 12:08h Op-Eds

Share

Joseph Allen
IPWatchdog, 7/21/2024 ...

Read More

19 Jul Don’t Justify March-in With Myth That ‘Government Funds Drugs’

Posted at 14:22h Op-Eds

Share

Fred Reinhart & Mark Rohrbaugh
RealClearHealth, 7/19/2024 ...

Read More

16 Jul Bayh-Dole Coalition Comments on NIH Intramural Licensing Guidelines, 7/16/2024

Posted at 10:59h Public Comments

Share

Read More

01 Jul Cassidy Targets March-In Rights Again After Supreme Court’s Ruling On Chevron Deference

Posted at 12:33h Other Media

Share

Jalen Brown and Gabrielle Wanneh
Inside Health Policy, 7/1/2024...

Read More

20 Jun This law made ORNL a commercial powerhouse. A federal agency could jeopardize it

Posted at 11:25h Other Media

Share

Daniel Dassow
Knoxville News Sentinel, 6/20/2024...

Read More

13 Jun Federal policy changes would hamstring Pennsylvania’s economy and hurt patients

Posted at 11:48h Op-Eds

Share

Steven Infanti
The Patriot-News, 6/12/2024...

Read More

04 Jun A debate over a federal bill that has played a key role in medical innovation

Posted at 15:40h Other Media

Share

Joseph P. Allen
The Washington Post, 6/4/2024 ...

Read More

20 May Bayh-Dole Coalition Letter to Senate Judiciary Committee RE: “Examining Competition in the Prescription Drug Market,” 5/20/2024

Posted at 12:21h Letters

Share

Read More

16 May Bayh-Dole Coalition Letter to Senate Commerce, Science, & Transportation Committee RE: “Invent Here, Make Here Act of 2023,” 5/13/2024

Posted at 10:46h Letters

Share

Read More

16 May Industry Tells USPTO Biden March-In Proposal Undermines Inquiry to Improve IP Commercialization

Posted at 10:35h Other Media

Share

Eileen McDermott
IPWatchdog, 5/16/2024...

Read More